Zelnorm tegaserod regulatory update

FDA approved an sNDA for Zelnorm, a serotonin (5-HT4) receptor agonist, to treat chronic constipation in patients less than 65 years old. Zelnorm was approved in 2002 for short-term treatment of wome...